Infusion of hESC derived Immunity‐and‐matrix regulatory cells improves cognitive ability in early‐stage AD mice

OBJECTIVES: In this study, we administered immunity‐and‐matrix regulatory cells (IMRCs) via tail vein (IV) and intracerebroventricular (ICV) injection to 3‐month‐old 5×FAD transgenic mice to assess the effects of IMRC transplantation on the behaviour and pathology of early‐stage Alzheimer's dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Hou, Zongren, Wu, Jun, Liu, Kailun, Li, Da, Gao, Tingting, Liu, Wenjing, An, Bin, Sun, Yun, Mo, Fan, Wang, Liu, Wang, Yukai, Hao, Jie, Hu, Baoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349653/
https://www.ncbi.nlm.nih.gov/pubmed/34232542
http://dx.doi.org/10.1111/cpr.13085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349653/
https://www.ncbi.nlm.nih.gov/pubmed/34232542
http://dx.doi.org/10.1111/cpr.13085

Ejemplares similares